Archives

by in
Entry Author Date Location
Biotech in the Belt-Tightening Era: The Photos 04/12/13 Seattle
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Adaptive Biotechnologies Reaches Fork in the Road. What to Charge? 04/03/13 Seattle
How to Make the Payers Pay: Join the Xconomy Event April 9 03/26/13 Seattle
Biotech for the Belt-Tightening Era: Last Chance For Early-Bird Tix 03/12/13 Seattle
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Join Us at “Biotech in the Belt-Tightening Era” April 9 in Seattle 02/14/13 Seattle
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Seattle Genetics, Millennium Cancer Drug Cleared in EU 10/31/12 Seattle
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Seattle Genetics Gets $34.7M in Second-Quarter Sales of Cancer Drug 08/08/12 Seattle
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Seattle Genetics, Millennium Get EU Recommendation for Lymphoma Drug 07/20/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
The Best Boring Companies in Biotech 07/09/12 National
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push 05/29/12 Seattle
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Page 1 of 8 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.